Chandra Bhagat Pharma Limited (BOM:542934)

Market Cap	290.48M -75.1%
Revenue (ttm)	493.95M -70.6%
Net Income	6.22M -60.6%
EPS	0.83 -60.6%
Shares Out	7.55M
PE Ratio	46.57
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Average Volume	9,200
Open	38.50
Previous Close	39.50
Day's Range	38.50 - 38.50
52-Week Range	33.00 - 68.99
Beta	-0.76
RSI	40.80
Earnings Date	Feb 12, 2026

About Chandra Bhagat Pharma

Chandra Bhagat Pharma Limited engages in the marketing of pharmaceutical critical care and health care products in India and internationally. It offers pharmaceutical formulations, including intravenous and intramuscular injections, tablets, and capsules in various therapeutic categories, such as anti-cancer, antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, anti-fungal, antiviral, pediatrics, cardiology, nephrology, and neurology to Hospitals and Health care Centers through distribution networks and sales force under its ...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1944
• Employees: 40
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 542934

Financial Performance

In fiscal year 2025, Chandra Bhagat Pharma's revenue was 887.67 million, a decrease of -60.11% compared to the previous year's 2.23 billion. Earnings were 8.58 million, a decrease of -43.95%.